Continuous glucose monitoring in non-insulin-dependent type-2 diabetes - rationale for CGM-NIDDM study.
Diabetol Metab Syndr. 2025.
PMID: 41102769
Free PMC article.
Review.
Search Page
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 2007 | 1 |
| 2008 | 3 |
| 2009 | 5 |
| 2010 | 3 |
| 2011 | 10 |
| 2012 | 10 |
| 2013 | 11 |
| 2014 | 12 |
| 2015 | 11 |
| 2016 | 13 |
| 2017 | 15 |
| 2018 | 30 |
| 2019 | 18 |
| 2020 | 25 |
| 2021 | 52 |
| 2022 | 37 |
| 2023 | 46 |
| 2024 | 48 |
| 2025 | 58 |
| 2026 | 36 |
Search Results
380 results
Results by year
Citations
2
articles
found by citation matching
A Podcast on the Use of CGM in Optimizing Type 2 Diabetes Management with Non-intensive Insulin Treatment in the Primary Care Setting.
Diabetes Ther. 2024.
PMID: 38216832
Free PMC article.
Search results
Page 1
Did you mean
cm type 2 diabetes non insulin
(563 results)?
Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin: A Randomized Clinical Trial.
JAMA. 2021 Jun 8;325(22):2262-2272. doi: 10.1001/jama.2021.7444.
JAMA. 2021.
PMID: 34077499
Free PMC article.
Clinical Trial.
IMPORTANCE: Continuous glucose monitoring (CGM) has been shown to be beneficial for adults with type 2 diabetes using intensive insulin therapy, but its use in type 2 diabetes treated with basal insulin without prandi …
IMPORTANCE: Continuous glucose monitoring (CGM) has been shown to be beneficial for adults with type 2 diabetes …
Continuous glucose monitoring in adults with type 2 diabetes: a systematic review and meta-analysis.
Diabetologia. 2024 May;67(5):798-810. doi: 10.1007/s00125-024-06107-6. Epub 2024 Feb 16.
Diabetologia. 2024.
PMID: 38363342
Free PMC article.
AIMS/HYPOTHESIS: Continuous glucose monitoring (CGM) is increasingly used in the treatment of type 2 diabetes, but the effects on glycaemic control are unclear. ...We included RCTs investigating real-time CGM (rtCGM) or intermittently scanned …
AIMS/HYPOTHESIS: Continuous glucose monitoring (CGM) is increasingly used in the treatment of type 2 diabetes, b …
Continuous glucose monitoring for the routine care of type 2 diabetes mellitus.
Nat Rev Endocrinol. 2024 Jul;20(7):426-440. doi: 10.1038/s41574-024-00973-1. Epub 2024 Apr 8.
Nat Rev Endocrinol. 2024.
PMID: 38589493
Free article.
Review.
Although continuous glucose monitoring (CGM) devices are now considered the standard of care for people with type 1 diabetes mellitus, the uptake among people with type 2 diabetes mellitus (T2DM) has been slower and is focused on those receiving …
Although continuous glucose monitoring (CGM) devices are now considered the standard of care for people with type 1 diabetes mellitus …
Effect of a ketogenic diet versus Mediterranean diet on glycated hemoglobin in individuals with prediabetes and type 2 diabetes mellitus: The interventional Keto-Med randomized crossover trial.
Am J Clin Nutr. 2022 Sep 2;116(3):640-652. doi: 10.1093/ajcn/nqac154.
Am J Clin Nutr. 2022.
PMID: 35641199
Free PMC article.
Clinical Trial.
BACKGROUND: Consensus has not been reached on what constitutes an optimal diet in individuals with prediabetes and type 2 diabetes mellitus (T2DM), especially between low-carbohydrate options. OBJECTIVES: We compared 2 low-carbohydrate diets with 3 key …
BACKGROUND: Consensus has not been reached on what constitutes an optimal diet in individuals with prediabetes and type 2 d …
IMpact of flash glucose Monitoring in pEople with type 2 Diabetes Inadequately controlled with non-insulin Antihyperglycaemic ThErapy (IMMEDIATE): A randomized controlled trial.
Diabetes Obes Metab. 2023 Apr;25(4):1024-1031. doi: 10.1111/dom.14949. Epub 2023 Jan 11.
Diabetes Obes Metab. 2023.
PMID: 36546594
Clinical Trial.
Adults with type 2 diabetes using at least one non-insulin therapy, with an HbA1c of 7.5% or higher ( 58 mmol/mol), were randomized 1:1 to receive an isCGM device plus diabetes self-management education (isCGM + DSME) or DSME alone. ...CONCLUSI …
Adults with type 2 diabetes using at least one non-insulin therapy, with an HbA1c of 7.5% or higher ( 58 …
The effectiveness of continuous glucose monitoring with remote telemonitoring-enabled virtual educator visits in adults with non-insulin dependent type 2 diabetes: A randomized trial.
Diabetes Res Clin Pract. 2024 Nov;217:111899. doi: 10.1016/j.diabres.2024.111899. Epub 2024 Oct 19.
Diabetes Res Clin Pract. 2024.
PMID: 39433218
Free article.
Clinical Trial.
AIMS: Estimate the effectiveness of continuous glucose monitoring (CGM) with remote telemonitoring-enabled virtual diabetes educator visits for improving glycemic management in adults with type 2 diabetes, not on insulin. METHODS: Participants w …
AIMS: Estimate the effectiveness of continuous glucose monitoring (CGM) with remote telemonitoring-enabled virtual diabetes educator …
Efficacy of once-weekly tirzepatide versus once-daily insulin degludec on glycaemic control measured by continuous glucose monitoring in adults with type 2 diabetes (SURPASS-3 CGM): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial.
Lancet Diabetes Endocrinol. 2022 Jun;10(6):407-417. doi: 10.1016/S2213-8587(22)00077-8. Epub 2022 Apr 22.
Lancet Diabetes Endocrinol. 2022.
PMID: 35468321
Clinical Trial.
BACKGROUND: Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist under development for the treatment of type 2 diabetes. In this study, we used continuous glucose monitoring (CGM) to compare the 24 h …
BACKGROUND: Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist under development for …
Application of continuous glucose monitoring and automated insulin delivery technologies for pregnant women with type 1, type 2, or gestational diabetes: an international consensus statement.
Lancet Diabetes Endocrinol. 2026 Feb;14(2):157-177. doi: 10.1016/S2213-8587(25)00335-3. Epub 2025 Dec 17.
Lancet Diabetes Endocrinol. 2026.
PMID: 41421368
Free article.
Review.
Insulin resistance increases after the first trimester of pregnancy, leading to glycaemic challenges for women with pregestational type 1 diabetes or type 2 diabetes. Additionally, insulin resistance can promote hyperglycaemia in pregnant women …
Insulin resistance increases after the first trimester of pregnancy, leading to glycaemic challenges for women with pregestational ty …
Complications of Diabetes and Metrics of Glycemic Management Derived From Continuous Glucose Monitoring.
J Clin Endocrinol Metab. 2022 May 17;107(6):e2221-e2236. doi: 10.1210/clinem/dgac034.
J Clin Endocrinol Metab. 2022.
PMID: 35094087
Free PMC article.
Review.
This review summarizes the relationship between continuous glucose monitoring (CGM)-derived metrics of glycemic variability and diabetes-related complications. EVIDENCE ACQUISITION: PubMed and Embase databases were searched from January 1, 2010 to August 22, 2020, using th …
This review summarizes the relationship between continuous glucose monitoring (CGM)-derived metrics of glycemic variability and diabe …
Continuous Glucose Monitoring and Physical Activity.
Int J Environ Res Public Health. 2022 Sep 28;19(19):12296. doi: 10.3390/ijerph191912296.
Int J Environ Res Public Health. 2022.
PMID: 36231598
Free PMC article.
Review.
Physical activity is a recommended intervention tool in diabetes management, especially for people with type 2 diabetes (T2D). The benefits of physical activity for people with diabetes can be seen as an improvement of glycemic control, glycemic variability, …
Physical activity is a recommended intervention tool in diabetes management, especially for people with type 2 diabetes …
Cite